Edwards Lifesciences v. CoreValve

April 2, 2010

WILMINGTON, DE – A federal jury ordered Medtronic Inc. to pay $73.5 million to Edwards Lifesciences Corp. for violating a patent on Edwards’ Sapien XT heart valve.

The jury found that Medtronic’s CoreValve business willfully infringed on a patent that relates to an artificial valve that is implanted through a catheter.

Edwards LifeSciences was represented at the trial by a team led by partners John Nathan and Catherine Nyarady (Paul Weiss).  The Impact Trial team consisted of Jesse W. Stevenson, Joel DePalma and Kara Lyon who worked closely with the trial team providing them with invaluable trial technology and litigation graphics consulting and support through the trial.

The case is Edwards Lifesciences, et al. v. CoreValve, et al., case number 1:08-cv-00091, in the U.S. District Court for the District of Delaware.